April 13, 2020 IntegriChain Acquires the Life Sciences Division of Cumberland, Creating the Largest Data and Business Process Platform for Market Access and Commercialization of Specialty, Precision, and Retail Pharmaceuticals IntegriChain has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. With this acquisition, IntegriChain delivers the Life Science industry’s most comprehensive and scalable data and business process platform for commercialization and market access of cell and gene therapy, specialty, and retail pharmaceuticals.
January 8, 2020 IntegriChain Supported 65+ Life Sciences Launches in Last 36 Months IntegriChain today announced that the company has supported more than 65 launches of innovative therapies including cell and gene therapy (CGT) and orphan & rare diseases (ORD) during the last three years. Emerging Life Sciences manufacturers have engaged IntegriChain for its best-in-class comprehensive commercialization platform, including channel and patient data stewardship and managed services to stand up their business infrastructure for all aspects of patient access: contracts and pricing, gross-to-net, channel, and patient services.
December 3, 2019 IntegriChain Implements Data-Science-Driven Stewardship of Specialty Pharmacy Data for Multiple Top-30 Life Sciences Manufacturers IntegriChain announced that multiple top-30 Life Sciences manufacturers have implemented its stewardship and refining solutions to improve the quality and actionability of specialty pharmacy data. These solutions, based on recent data science advancements in the ICyte Platform, overcome the industry challenge of immature patient data sets that includes non-standardize data from hundreds of data suppliers delivered with varied quality. IntegriChain Co-Founder and EVP Josh Halpern will present more on this topic during his presentation, “The State of Patient Status Visibility and the Use of Artificial Intelligence to Drive Specialty Channel Insights,” at CBI Trade & Channel, beginning today in Philadelphia.
November 12, 2019 IntegriChain Gross-to-Net Automation Goes Live with Akcea Therapeutics IntegriChain completes implementation of its Gross-to-Net (GTN) Managed Services with Akcea Therapeutics. IntegriChain GTN Solutions, which are built to industry best practices and are scalable and auditable, deliver end-to-end revenue management for Life Sciences Market Access and Finance teams that improves forecast accuracy, GTN modeling, and financial close efficiency. IntegriChain also is finalizing the implementation-readiness process for five additional GTN Managed Services customers.
November 6, 2019 IntegriChain to Present at Upcoming AGC Partners’ and Lincoln International’s Investor Conferences IntegriChain Co-Founder and CEO, Kevin Leininger, will speak at upcoming investor conferences. Leininger will present a company overview at AGC Partners’ 2019 Boston Technology Growth Conference on Thursday, November 7, and Lincoln International’s 2019 Growth Conference November 18 in Chicago.
November 1, 2019 IntegriChain Presents Annual Customer Awards to Akcea Therapeutics, GSK, Johnson & Johnson and Spark Therapeutics IntegriChain presented its annual customer awards last week at the Access Insights Conference. The company awards included Best Commercialization Launch awarded to Spark Therapeutics, the Trade & Channel Innovator awarded to GSK, and the Trailblazer of the Year awarded to Akcea Therapeutics. An individual award, the ICyte Power User Award, was presented to Allyson S. Johnston, Manager, Trade & Patient Access Analytics, for Johnson & Johnson.
October 28, 2019 IntegriChain Named to Philadelphia100 List of Fastest Growing Private Companies IntegriChain has been named to thePhiladelphia100 list of fastest growing, privately held entrepreneurial companies. IntegriChain placed 29th on the Philadelphia100 list in an awards ceremony last week.
October 21, 2019 IntegriChain Access Insights Conference Breaks Attendance Records IntegriChain broke attendance records with more than 190 participants, including seven ecosystem partners and sponsors and more than 25 industry speakers.
August 14, 2019 IntegriChain Expands Footprint in Gartner Hype Cycle for Life Sciences Commercial Operations IntegriChain announces that it was recognized in two areas of Gartner’s Hype Cycle for Life Sciences Commercial Operations 2019, which is available on Gartner.com. IntegriChain is included as a sample vendor for both Revenue Management and Life Sciences Commercial Analytics.
